Previous Article | Next Article 
Molecular and Cellular Biology, February 2000, p. 1407-1418, Vol. 20, No. 4
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Novel TATA-Binding Protein-Binding Protein, ABT1,
Activates Basal Transcription and Has a Yeast Homolog That Is
Essential for Growth
Tsukasa
Oda,1
Kentaro
Kayukawa,2
Hiroko
Hagiwara,3
Henrik T.
Yudate,1
Yasuhiko
Masuho,1
Yasufumi
Murakami,3
Taka-aki
Tamura,2 and
Masa-aki
Muramatsu1,4,*
Helix Research Institute, Inc., Kisarazu-shi,
Chiba 292-0812,1 Department of Biology,
Faculty of Science, Chiba University, Inage-ku, Chiba
263-8522,2 Cellular Physiology
Laboratory, The Institute of Physical and Chemical Research (RIKEN),
Tsukuba-shi, Ibaraki 305-0074,3 and
Department of Biological Cybernetics, Medical Research
Institute, Tokyo Medical Dental University, Bunkyo-ku, Tokyo
113-8510,4 Japan
Received 21 June 1999/Returned for modification 25 October
1999/Accepted 22 November 1999
 |
ABSTRACT |
Identification of a novel mouse nuclear protein termed activator of
basal transcription 1 (mABT1) that associates with the TATA-binding
protein (TBP) and enhances basal transcription activity of class II
promoters is described. We also identify mABT1 homologous counterparts
in Caenorhabditis elegans and Saccharomyces
cerevisiae and show the homologous yeast gene to be essential for
growth. The mABT1 associated with TBP in HeLa nuclear extracts and with purified mouse TBP in vitro. In addition, ectopically expressed mABT1
was coimmunoprecipitated with endogenous TBP in transfected cells. More
importantly, mABT1 significantly enhanced transcription from an
adenovirus major late promoter in a reconstituted cell-free system. We
furthermore demonstrate that mABT1 consistently enhanced transcription
from a reporter gene with a minimal core promoter as well as from
reporter genes with various enhancer elements in a cotransfection
assay. Taken together, these results suggest that mABT1 is a novel
TBP-binding protein which can function as a basal transcription activator.
 |
INTRODUCTION |
Most genes in eukaryotes show a
regulated pattern of expression during the course of development, in
the cell cycle, or in response to changes in the cellular environment.
The protein-coding genes transcribed by RNA polymerase II (Pol II) are
predominantly regulated at the level of transcription (4, 6,
53), and this transcriptional control of RNA Pol II is governed
by specific DNA elements and protein factors assembled on these
elements. Two types of DNA elements exist: (i) common core promoter
elements on which RNA Pol II and general transcription factors (GTFs)
such as TFIIA, -B, -D, -E, -F, and -H assemble to form a preinitiation complex and (ii) gene-specific DNA elements that are recognized by
regulatory factors (53, 56). According to this scheme, RNA Pol II and cognate GTFs can initiate a low level of intrinsic basal
transcription from the core promoter. This basal transcription machinery is an ultimate target of various gene- and cell type-specific regulatory factors, which lend positive and negative signals to modulate transcriptional activity.
The TATA-binding protein (TBP) has been isolated and characterized as a
TATA element-binding component of the general transcription factor
TFIID (13, 20, 22, 23, 25, 32). TBP is associated with a
variety of factors that play important roles in basal or gene-specific
regulation of gene expression. For example, TBP interacts with
TBP-associated factors (TAFIIs) and forms the TFIID complex, which was initially identified as an essential GTF. Mammalian or Drosophila TFIID can mediate basal and activated
transcription in vitro, whereas TBP by itself can mediate only basal
transcription, suggesting that mammalian or Drosophila
TAFIIs are required for activated transcription (50,
67). While TAFIIs have been proposed to be
coactivators that mediate activated transcription, recent studies have
shown that TAFIIs have multiple functions including core
promoter-selective basal transcription (41, 47, 59), histone
acetyltransferase activity (46), and phosphorylation of
TFIIF (8). TAFIIs consist of multiproteins
ranging in size from 18 to 250 kDa (39, 40). Major
TAFIIs have been cloned from yeast, fly, and mammalian
cells, and most of the counterparts show remarkable evolutionary
conservation. Eleven out of twelve yeast TAFIIs are
essential for cell viability (39), indicating the importance
of TAFIIs for transcription in eukaryotes.
TBP plays a key role together with TAFIIs in communicating
transcriptional regulatory factors and in the basic transcription machinery (67). TBP binds to a variety of factors including c-Fos (45, 52), c-Myc (18, 40), and p53 (58,
64). More recently, other TBP-binding proteins, such as SAGA
(3, 10, 55), Mot1 (1, 2, 69), NC2 (17, 26,
33, 42, 44), and NOTs (38), that control class II
genes have been found. To account for the diversity of regulation
mechanisms of class II genes, it is anticipated that many more factors
may be involved in transcription regulation through the TBP.
Here we report cloning and characterization of a novel mouse nuclear
protein named activator of basal transcription 1 (mABT1). mABT1 was
isolated during the course of yeast two-hybrid screening using the Src
homology 2 (SH2) domain of SHD, a previously identified SH2
domain-containing protein (48). The analysis carried out in
this study showed that mABT1 associated directly with TBP and activated
transcription from an adenovirus major late (AdML) promoter in a
cell-free system. Also, expression of mABT1 in mammalian cells was
observed to stimulate gene expression regardless of cis-regulatory elements, and we demonstrate that only the
core promoter was required for activation. Furthermore, the
Saccharomyces cerevisiae yeast counterpart of the mABT1 gene
was shown to be essential for growth. These lines of evidence
characterizes mABT1 as a novel TBP-binding protein which promotes
activation of basal transcription.
 |
MATERIALS AND METHODS |
Molecular cloning of mABT1 cDNA.
pB42AD-mABT1, which
contains the mouse ABT1 cDNA, was isolated from the Mouse Embryo
MATCHMAKER LexA cDNA Library (Clontech) using the SH2 domain of SHD
(48). Both strands of the mABT1 cDNA were sequenced with an
ABI 377 DNA sequencer (Perkin-Elmer). Human ABT1 cDNA was cloned from
the NT2 human teratocarcinoma cell line by rapid amplification of 5'
cDNA ends (5'-RACE) (GIBCO BRL) according to the supplier's
instructions. The primer sequences 5'-TGC CTG GAC TAG GCA TTA TCC-3'
and 5'-TTG GAA ATA AAG GCC CTT TCT-3', used for first-strand cDNA
synthesis and PCR, respectively, were obtained from the expressed
sequence tags database (dbEST). The PCR product was subcloned in a
pT7Blue T-vector (Novagen) and sequenced. The Caenorhabditis
elegans ABT1 cDNA was cloned by reverse transcription-PCR (RT-PCR)
with primers 5'-TTT GAA TTC ATG GCG CCT ATT CCA AAA AAG-3' and 5'-GAG
AGG ATC CTT ATT TGA AGA TCA TAT TCA TCA ATT C-3'. The PCR product was
subcloned in the pT7Blue T-vector and sequenced.
Northern blot analysis.
A mouse multiple-tissue Northern
blot (Clontech) was prehybridized and hybridized in ExpressHyb
hybridization solution (Clontech) at 65°C with a
32P-labeled mABT1 cDNA probe. The blot was washed twice for
1 h at room temperature in a solution containing 0.3 M NaCl, 0.03 M sodium citrate, and 0.1% sodium dodecyl sulfate (SDS), then washed
for 1 h at 65°C in a solution containing 15 mM NaCl, 1.5 mM
sodium citrate, 0.1% SDS, and thereafter subjected to autoradiography.
Western blot analysis.
Proteins were separated by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto
polyvinylidene difluoride membranes (Bio-Rad) with a semidry transfer
cell (Bio-Rad). Residual binding sites were blocked by overnight
incubation at 4°C in phosphate-buffered saline (PBS; 136.9 mM NaCl,
2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4) containing 0.05% Tween 20 and 5%
nonfat milk. The blots were incubated for 4 to 16 h at 4°C with
primary antibody. Antibody reactions were detected using anti-mouse or
anti-rabbit antibody conjugated to horseradish peroxidase (Amersham)
and visualized by enhanced Luminol reagent (NEN).
Cell culture and transfections.
COS7 cells were cultured in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10%
fetal bovine serum (FBS), penicillin, and streptomycin. The cells were
plated approximately 16 h before transfection at a density of
2.0 × 105 cells in a well of 35-mm-diameter multiwell
plate (Falcon). Plasmids (2 µg) were preincubated with 13 µl of
Lipofectamine (GIBCO BRL) in 200 µl of serum-free DMEM at room
temperature for 45 min. The cells were washed once with DMEM. The
preincubated mixture was diluted with DMEM to a final volume of 1 ml
and added to the cells. The cells were then incubated for 5 h at
37°C, and FBS or bovine serum albumin (BSA) was added to a final
concentration of 10 or 1%, respectively. At 24 h after
transfection, the cells were washed once with DMEM and then incubated
for 24 h in DMEM-10% FBS or in DMEM-1% BSA. At 48 h after
transfection, the cells were washed twice with cold PBS and lysed in
150 µl of lysis buffer (25 mM glycylglycine [pH 7.8], 15%
glycerol, 8 mM MgSO4, 1 mM EDTA, 1% Triton X-100, 1 mM
dithiothreitol [DTT]), followed by incubation for an additional 20 min at 4°C. The cell lysates were transferred to a 1.5-ml tube and
centrifuged, and 10 µl of the supernatant was used for luciferase assay.
Plasmids.
pcDNA3-myc was constructed by inserting the
annealed primers 5'-A GCT GCC ATG GAA CAA AAA CTC ATC TCA GAA GAG GAT
CTG GGA TCC AAG CTT G-3' and 5'-AA TTC AAG CTT GGA TCC CAG ATC CTC TTC TGA GAT GAG TTT TTG TTC CAT GGC-3' into the HindIII and
EcoRI sites of pcDNA3 (Invitrogen). pcDNA3-mABT1 and
pcDNA3-myc-mABT1 were constructed by subcloning the
EcoRI-XhoI cDNA fragment of pB42AD-mABT1, which
was isolated from the mouse cDNA library, into the EcoRI and
XhoI sites of pcDNA3 and pcDNA3-myc, respectively. pFA-CREB,
pFA-cFos, pFA-ATF2, pCRE-Luc, pSRE-Luc, pAP1-Luc, and pNF-
B-Luc were
purchased from Stratagene. pTATA-Luc was constructed by removing AP-1
binding sequences from plasmid pAP1-Luc. Two oligonucleotides (5'-CGC
AAG CTT GCG GAG ACT CTA GAG GG-3' and 5'-TTC TGC CCG AAC GG-3') were
used for PCR to amplify a sequence containing the TATA box and part of
the luciferase coding sequences from pAP1-Luc. The PCR product was
digested and replaced with the HindIII-SplI
fragment of pAP1-Luc, which contains seven AP-1 binding sites, the TATA
box, and the luciferase coding sequence. pEGFP-mABT1 was constructed by
subcloning the EcoRI-XhoI fragment of
pB42AD-mABT1 into the EcoRI-SalI site of pEGFP-C2
(Clontech). pGEX-mABT1 was constructed by subcloning the
EcoRI-XhoI fragment of pB42AD-mABT1 in the
EcoRI-XhoI site of pGEX-4T-1 (Pharmacia). pGEX-mABT1 mutant plasmids were constructed by subcloning the EcoRI-XhoI fragment of the PCR products amplified
from pcDNA3-myc-mABT1 into the EcoRI-XhoI site of
pGEX-4T-1. The oligonucleotide sequences used for amplifying the
fragments of mABT1 cDNA were pcDNA3-S (5'-TAA TAC GAC TCA CTA TAG-3'),
pcDNA3-AS (5'-ATT TAG GTG ACA CTA TAG-3'), A34 (5'-TTT GAA TTC ATG GCC
TGC AGC GCA-3'), A97 (5'-TTT GAA TTC GGA GGA AAG AAG GGA GCT-3'), A39
(5'-TTT CTC GAG GCT GCT GCT GCT GCA GGC-3'), A102 (5'-TTT CTC GAG AGC
TCC CTT CTT TCC TCC-3'), and A204 (5'-TTT CTC GAG ATC CCC ATC AGC TGC AAG-3'). Combinations of oligonucleotides for PCR were as follows: A34
and pcDNA3-AS for mABT1(34-269), pcDNA3-S and A39 for mABT1(1-39), pcDNA3-S and A102 for mABT1(1-102), pcDNA3-S and A204 for mABT1(1-204), A34 and A102 for mABT1(34-102), A97 and A204 for mABT1(97-204), and A34
and A204 for mABT1(34-204).
GST fusion protein binding assays.
Escherichia coli
JM109 transformed with pGEX plasmids was inoculated in 20 ml of
Luria-Bertani medium containing ampicillin (100 µg/ml) and cultured
overnight at 37°C. The cultures were diluted 1:10 in 200 ml of the
same medium and cultured at 25°C until the optical density at 600 nm
reached 0.8; then glutathione S-transferase (GST) fusion
proteins were induced by adding
isopropyl-
-D-thiogalactopyranoside (IPTG) to a final
concentration of 0.2 mM. E. coli was collected after 20 h of incubation with IPTG at 25°C and resuspended in 20 ml of PBS
containing 0.2 mM phenylmethylsulfonyl fluoride. The E. coli
suspension was sonicated followed by incubation in the presence of 1%
Triton X-100 for 30 min at 4°C. The suspension was centrifuged, and
supernatants were incubated with glutathione-Sepharose 4B (Pharmacia)
to immobilize the GST fusion proteins on the Sepharose beads. HeLa
nuclear extract was prepared as follows. HeLa cells growing in log
phase were collected and washed twice with PBS containing 0.5 mM
MgCl2 and twice with buffer A (10 mM Tris-HCl [pH 7.5],
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT). The cells resuspended in buffer A were homogenized with a Potter-Elvehjem homogenizer and
centrifuged. After removing supernatants, pellets were resuspended in
buffer C (20 mM Tris-HCl [pH 7.5], 0.2 mM EDTA, 0.45 M NaCl, 5 mM
MgCl2, 0.5 mM DTT, 25% glycerol) and then homogenized with a Potter-Elvehjem homogenizer. The homogenates were transferred to a
centrifuge tube and rocked at 4°C for 30 min. The homogenates were
then centrifuged, and supernatants were collected as HeLa nuclear
extracts. At this point, 4 ml of nuclear extracts was obtained from
5 × 107 cells. The GST fusion protein-Sepharose beads
(the amounts of the GST fusion protein and the volume of the Sepharose
beads were normalized to approximately 5 µg and 15 µl,
respectively) were incubated overnight at 4°C with 200 µl of the
HeLa nuclear extracts or approximately 5 ng of recombinant
histidine-tagged mouse TBP (His-mTBP) and then washed four times with
PBS containing 0.1% Triton X-100. Proteins bound to the Sepharose
beads were used for Western blot analysis.
Immunoprecipitation.
COS7 cells (1.2 × 106
cells) were transfected with 12 µg of pcDNA3-myc-mABT1 and 75 µl of
Lipofectamine as described above. At 48 h after transfection,
cells were lysed with 1 ml of NP-40 buffer (20 mM Tris [pH 8.0], 1 mM
EDTA, 150 mM NaCl, 1% NP-40, 10% glycerol) containing aprotinin (10 µg/ml), leupeptin (10 µg/ml), trypsin inhibitor (10 µg/ml),
pepstatin A (2 µg/ml), 0.2 mM phenylmethylsulfonyl fluoride, and 1 mM
DTT. Lysates were centrifuged, and 400 µl of the supernatants was
incubated with an anti-TBP antibody or with a control rabbit
immunoglobulin G (IgG) at 4°C for 16 h. Subsequently, 7 µl
each of protein A-Sepharose beads and protein G-Sepharose beads were
added to the mixture and incubated at 4°C for 2 h to absorb the
immunocomplex. The Sepharose beads were washed four times with 1 ml of
PBS containing 0.1% Triton X-100, and proteins bound to the Sepharose
beads were separated by SDS-PAGE and immunoblotted with an anti-Myc or
anti-TBP antibody.
RT-PCR.
Two micrograms of total RNAs isolated from COS7
cells with TRIZOL (GIBCO BRL) was treated with DNase I (GIBCO BRL).
Reverse transcription by SuperscriptII (GIBCO BRL) was performed with the RNA samples and random hexamers. The DNA fragment corresponding to
the partial sequences of exogenously transfected GAL4-CREB gene was
selectively amplified by PCR by using two oligonucleotides (5'-ATT GGC
TTC AGT GGA GAC-3' and 5'-GAA TCA GTT ACA CTA TCC-3'). PCRs were
performed for 35 cycles with denaturation at 94°C for 1 min,
annealing at 44°C for 1 min, and polymerization at 72°C for 1 min.
The PCR products were separated electrophoretically in an agarose gel
and stained with ethidium bromide.
mABT1 localization.
pEGFP-mABT1 plasmids were transfected in
COS7 cells with Lipofectamine as described above. At 24 h after
transfection, localization of the enhanced green fluorescent protein
(EGFP)-mABT1 fusion proteins were observed by fluorescence microscopy
with an Axiovert 135 microscope (Zeiss).
Disruption of yeast ABT1 gene.
DNA fragments with the yeast
ABT1 homologous DNA ends were generated by PCR using the template
pFA6a-KanMX4, which contains the known Kanr open reading
frame and permits efficient selection of transformants resistant to
Geneticin (G418) (68), and the two primers 5'-AGC AAA CAG
TTT ACT GCA GCA GAG TGA AGT AAA TTT TTA CGC CGT ACG CTG CAG GTC GAC-3'
and 5'-AGC ATT GGC CAC GGC TTG TTT CCA CAC GAC GTT GTT TAA ATT ATC GAT
GAA TTC GAG CTC G-3'. The PCR was carried out with 25 pmol of the
primers, 50 ng of template, 250 µM each deoxynucleoside
triphosphates, 2 mM MgCl2, 1× KOD polymerase buffer, and
2.5 Unit of KOD polymerase (Toyobo). The program for the PCR consisted
of 40 cycles of 15 s at 95°C, 30 s at 60°C, and 60 s at 74°C. S. cerevisiae C110-1 (a/
leu2-3/leu2-3 leu2-112/leu2-112 ura3-52/ura3-52 his6/HIS6)
(66) was transformed with the resultant PCR fragment by the
lithium acetate method and selected on a YPD plate containing G418 (0.2 mg/ml). G418-resistant clones were isolated, and disruption of the
yeast ABT1 gene (YNR054c) was confirmed by PCR. For tetrad analysis,
the ABT1-disrupted clones were incubated at 25°C in 1% potassium
acetate to form spores; then separated spores were incubated on YPD
plates at 30°C for 3 days.
In vitro transcription assay.
The conditions for in vitro
transcription assays were as follows. The reaction mixture contained 10 mM HEPES-KOH (pH 7.6), 3% glycerol, 25 mM KCl, 6 mM MgCl2,
620 µM ATP and UTP, 25 µM CTP, 200 µM O-methyl-GTP, 5 µCi of [
-32P]CTP, 800 ng of template (which contains
the AdML promoter fused to the G-less cassette [57]),
50 ng of recombinant TFIIB, 120 ng of recombinant TFIIF, 45 ng of
recombinant TBP, 0.2 µg of RNA Pol II purified from calf thymus, and
different amounts of GST-mABT1 in a total volume of 20 µl. The
reaction mixture without nucleotides was incubated on ice for 20 min,
and nucleotides were then added to initiate RNA synthesis, which took
place at 27°C for 45 min. Synthesized RNA was extracted with
phenol-chloroform, precipitated with ethanol, and analyzed on a 5%
polyacrylamide-8-M urea gel.
DNA binding assay.
GST-mABT1 or GST protein (approximately 2 µg) was incubated with 15 µl of denatured or native DNA-cellulose
(Amersham Pharmacia Biotech) at 4°C for 4 h. The cellulose was
washed four times with PBS containing 0.1% Triton X-100. Proteins
bound to the cellulose were subjected to SDS-PAGE and then stained with
Coomassie brilliant blue.
Nucleotide sequence accession number.
The sequence data for
ABT1 have been submitted to the DDBJ/EMBL/GenBank databases with
accession no. AB021860 (mouse) and AB027258 (human).
 |
RESULTS |
Identification of mouse ABT1 and its homologs in human, yeast, and
nematode cells.
During identification of molecules interacting
with SHD by yeast two-hybrid screening, four independent cDNA clones
derived from the same gene were cloned from a mouse embryonic cell cDNA library. The representative clone, designated mABT1, has 1,276 bp and a
potential open reading frame of 269 amino acids (aa) (Fig.
1A). The sequence around
the putative ATG initiation codon at nucleotides 14 to 16 is compatible
with the Kozak consensus sequence. The 3' end is terminated with a
poly(A)+ tail preceded by a polyadenylation signal. This
clone covers an almost full-length mRNA of 1.4 kb as estimated by
Northern blot analysis (see below). A sequence similarity search in the GenBank database was performed using the mABT1 protein sequence as the
query, but no similar sequences with known function were found. mABT1
showed similarity only to the hypothetical proteins YNR054c of S. cerevisiae and F57B10.8 of C. elegans (GenBank
accession no. P53743 and AF039713, respectively). To determine whether the C. elegans counterpart is actually transcribed, we
performed RT-PCR and cloned a 0.8-kb cDNA. Sequence analysis revealed
that this cDNA encoded an open reading frame of 268 aa (Fig. 1B) and that it was identical to F57B10.8, which was predicted from the C. elegans genome sequence. According to the sequence
information of the 3' untranslated region of human ABT1 in dbEST, we
cloned a human ABT1 cDNA from NT2 human teratocarcinoma cells by
5'-RACE. The human ABT1 cDNA encoded an open reading frame of 272 aa
(Fig. 1B). Sequence alignment of the mouse ABT1 protein and its human, S. cerevisiae, and C. elegans counterparts,
hABT1, ScABT1, and CeABT1, respectively, is shown in Fig. 1B. The amino
acid identities between mABT1 and the three homologs hABT1, ScABT1, and
CeABT1 to mABT1 are 75.6, 21.8, and 26.5%, respectively. The homology among these proteins was observed as small conserved stretches distributed throughout the whole sequence. No functional motifs except
for two putative nuclear localization signals were found in mABT1.
Although ABT1 lacked a typical DNA-binding motif, the N terminus of
mABT1 (aa 1 to 39), hABT1 (aa 1 to 39), ScABT1 (aa 1 to 86), and CeABT1
(aa 1 to 75) were rich in glutamic and aspartic acids (30.1, 41.0, 36.0, and 37.3%, respectively), suggesting that ABT1 might be a
transcription factor. Northern blot analysis of poly(A)+
RNA from a variety of murine tissues showed that the mRNA of mABT1 was
ubiquitously expressed as a transcript of approximately 1.4 kb (Fig.
1C).


View larger version (4382K):
[in this window]
[in a new window]
|
FIG. 1.
Structure of mABT1 and expression in mouse. (A)
Nucleotide and deduced amino acid sequences of the mouse ABT1 clone.
The 269 aa in the open reading frame are represented with one-letter
symbols. (B) Alignment of mouse, human, yeast, and nematode ABT1. The
hypothetical protein sequences of S. cerevisiae (YNR054),
C. elegans (F57B10.8), and human ABT1 exhibit high
similarity to the mABT1 sequence. Amino acid residues identical to
mABT1 are shown with a black background. Acidic regions of the four
ABT1s are indicated with arrows. (C) Northern blot analysis showing the
ubiquitous tissue expression of mABT1 mRNA in the mouse. mABT1 mRNA is
expressed as an approximately 1.4-kb transcript in all tissues
examined.
|
|
The yeast ABT1 homolog is essential for growth.
Since ABT1 is
conserved from yeast to mammalian cells, we anticipate that ABT1 might
have an important cellular function. As a step toward obtaining clues
for its function, we disrupted the ScABT1 gene (YNR054c). Two yeast
clones (ynr054c
-6 and ynr054c
-8) were generated in which a single
copy of the ScABT1 gene was deleted and replaced with a
Kanr gene (see Materials and Methods). The consequences of
this gene disruption were determined by sporulation and tetrad
analysis. Among the 40 tetrads dissected from ynr054c
-6 and
ynr054c
-8, 36 gave rise to only two viable spores that could grow on
YPD plates (Fig. 2). All viable progenies
were sensitive to G418, indicating that these haploids have intact
ScABT1 gene. This result clearly suggests that the yeast ABT1 is an
essential gene, and it is therefore appropriate to speculate that the
mammalian ABT1 also has an important function.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Yeast ABT1 gene is essential for growth. A single copy
of the ScABT1 gene in a diploid strain was disrupted, and tetrad
analysis were performed. Two independent yeast clones (ynr054 -6 and
ynr054c -8) were cultured in 1% potassium acetate at 25°C to form
spores. Spores derived from approximately 20 tetrads of each clone were
separated and incubated on YPD plates at 30°C for 3 days.
|
|
mABT1 is localized to the nucleus and nucleolus.
To determine
the subcellular localization of mouse ABT1, we transiently expressed in
COS7 cells the EGFP-mABT1 fusion protein. While a control EGFP
distributed both to the nucleus and the cytoplasm (data not shown), the
EGFP-mABT1 fusion protein was confined to the nucleus and in some cases
to the nucleolus (Fig. 3). Subcellular localization of hemagglutinin-tagged mABT1 (HA-mABT1) examined by an
anti-HA antibody, and immunofluorescence also confirmed nuclear
localization of mABT1 (data not shown). Although mABT1 possesses two
putative nuclear localization signals, KKKKK (40 to 44) and KRKKK (87 to 91), mABT1 mutants lacking either or both motifs still localized to
the nucleus (data not shown). Accordingly, these motifs are not
essential for nuclear localization of mABT1. There may be other nuclear
localization signals, or mABT1 may passively be transported into the
nucleus by diffusion due to its small size.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Subcellular localization of mABT1. COS7 cells were
transfected with pEGFP-mABT1; after 24 h, cells expressing EGFP
proteins were monitored by fluorescence microscopy under phase contrast
(A) and dark field (B).
|
|
mABT1 interacts with TBP.
Since an acidic region has been
reported to be the transcriptional activation domain in the
transcription factors VP16, GAL4, GCN4, and p53 (12, 15, 24, 49,
54, 64), we believe that the function of mABT1 may be related to
transcription. Many transcriptional activators and coactivators
participate in transcription by interacting with GTFs and especially
with TFIID. Thus, we first examined whether mABT1 associates with TBP,
one of the major components of TFIID. GST-mABT1 or GST alone was
immobilized on glutathione-Sepharose and incubated with nuclear extract
prepared from HeLa cells. Glutathione-Sepharose was washed either with
PBS containing 0.1% Triton X-100 or with 0.5 M LiCl, and the Sepharose
was collected. Proteins bound to GST-mABT1 or to GST were separated by
SDS-PAGE and immunoblotted with an anti-TBP antibody (Fig.
4A). A clear band with an approximate molecular mass of 37 kDa corresponding to human TBP was recognized by
the anti-TBP antibody when GST-mABT1 but not GST was incubated with the
HeLa nuclear extract (Fig. 4A, lanes 2 and 1, respectively). The TBP
band disappeared when the Sepharose was washed with 0.5 M LiCl (Fig.
4A, lane 4). The TBP band could also be detected when the Sepharose was
washed with NP-40 buffer but not when the Sepharose was washed with the
NP-40 buffer containing 0.1% SDS (data not shown). To further confirm
the interaction between mABT1 and TBP, we performed an
immunoprecipitation assay. Cell lysates from COS7 cells expressing
Myc-mABT1 were incubated with an anti-TBP antibody or a control rabbit
IgG. Subsequently, the immunocomplex was washed four times with PBS
containing 0.1% Triton X-100, separated by SDS-PAGE, and immunoblotted
with an anti-Myc antibody or anti-TBP antibody (Fig. 4B). Under these
experimental conditions, Myc-mABT1 coimmunoprecipitated with endogenous
TBP (Fig. 4B, lane 2), suggesting that mABT1 forms a complex with TBP
in transfected cells.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 4.
mABT1 interacts with TBP. (A) Interaction of GST-mABT1
with TBP in HeLa nuclear extracts (N.E.). The GST-mABT1 fusion protein
(lanes 2 and 4) and the GST protein (lanes 1 and 3) expressed in
E. coli were immobilized on glutathione-Sepharose beads and
incubated with HeLa nuclear extracts. After washing with PBS (136.9 mM
NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM
KH2PO4) containing 0.1% Triton X-100 (lanes 1 and 2) or with 0.5 M LiCl (lanes 3 and 4), proteins bound to the
Sepharose beads were subjected to SDS-PAGE and immunodetected with an
anti-TBP antibody. HeLa nuclear extracts were used as a positive
control (lane 5). The arrow indicates the TBP band, which is 37 kDa.
(B) Coimmunoprecipitation of mABT1 and TBP. COS7 cells were transfected
with pcDNA3-myc-mABT1, and lysate was prepared. Immunoprecipitations
with control rabbit IgG (lane 1) or anti-TBP antibody (lane 2) were
performed, and the immunocomplex was analyzed with antibodies against
TBP ( -TBP blot) and c-Myc ( -Myc blot). TBP and Myc-mABT1 in the
whole cell lysate are shown in lane 3. (C) Interaction of mABT1 with
purified mTBP. Recombinant His-mTBP was incubated with GST-mABT1 (lane
2) or GST (lane 1), and proteins bound to the Sepharose beads after
washing with PBS containing 0.1% Triton X-100 were subjected to
SDS-PAGE and immunodetection with an anti-His antibody. The arrow
indicates His-mTBP. (D) Stability of mABT1-TBP. The His-mTBP was
incubated with GST-mABT1 and washed with various concentrations of NaCl
(0.1 to 0.8 M) containing 0.1% Triton X-100. Then His-mTBP bound to
the GST-mABT1 was analyzed as described above.
|
|
Next, we examined whether mABT1 interacts directly with TBP.
Recombinant His-mTBP produced in
E. coli was incubated with
GST-mABT1
or GST alone. The Sepharose was washed with PBS, and proteins
bound to the Sepharose were analyzed by Western blotting with
an
anti-His antibody (Fig.
4C). A clear band corresponding to
His-mTBP was
detected with GST-mABT1 (Fig.
4C, lane 2) but was
only weakly detected
with GST (Fig.
4C, lane 1). This result indicates
that mABT1 and TBP
bind directly in vitro. To examine stability
of the binding between
mABT1 and TBP, we washed the Sepharose
with 0.1 to 0.8 M NaCl or 0.5 M
guanidium-HCl. His-mTBP and GST-mABT1
was existed as a complex up to
0.3 M NaCl but dissociated at NaCl
concentrations of 0.4 or higher
(Fig.
4D); 0.5 M guanidinium-HCl
also caused the His-mTBP-GST-mABT1
complex to dissociate (data
not
shown).
Region of mABT1 which binds to TBP.
For examination of the
TBP-binding region of mABT1, a series of GST-mABT1 fusion proteins
constructed from several different regions of mABT1 were generated in
E. coli and purified (Fig. 5A). HeLa nuclear extracts or His-mTBP
were mixed with these truncated mABT1 fusion proteins, and pull-down
experiments were performed. In HeLa nuclear extracts,
GST-mABT1(34-269), GST-mABT1(1-102), and GST-mABT1(1-204) were found to
interact with TBP (Fig. 5B, lanes 3, 5, and 6, respectively) as did the
GST-mABT1 wild type (WT) (Fig. 5B, lane 2). In contrast,
GST-mABT1(1-39) (Fig. 5B, lane 4) failed to interact with TBP. These
results indicate that the region in mABT1 comprising residues 34 to 102 is necessary for binding to TBP.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 5.
Delineation of the TBP-binding region of mABT1. (A)
Schematic representation of a series of GST-mABT1 mutants and summary
of the binding characteristics. Numbers show the sequence position of
amino acids in mABT1. Results of the interaction analysis with TBP in
HeLa nuclear extracts and purified His-mTBP are summarized to the right
( , interaction; ×, no interaction; ND, not determined). The binding
and washing conditions for TBP binding to the GST-mABT1 proteins were
the same as in Fig. 4C. (B) Interaction of the GST-mABT1 deletion
mutants with TBP in HeLa nuclear extracts. The series of GST-mABT1
deletion mutants were incubated with HeLa nuclear extracts and washed
with PBS containing Triton X-100. Proteins bound to the GST fusion
proteins were then detected by immunoblotting with an anti-TBP
antibody. Lane 1, GST; lane 2, mABT1 WT; lane 3; mABT1(34-269); lane 4, mABT1(1-39); lane 5, mABT1(1-102); lane 6, mABT1(1-204); lane 8, control HeLa nuclear extract (N.E.) (C) The series of GST-mABT1
deletion mutants were incubated with His-mTBP and washed with PBS
containing 0.1% Triton X-100. Proteins bound to the GST fusion
proteins were detected by immunoblotting with an anti-His antibody.
Lanes 1 and 7, GST; lanes 2 and 8, mABT1 WT; lane 3, mABT1(34-269);
lane 4, mABT1(1-39); lane 5, mABT1(1-102); lane 6, mABT1(1-204); lane
9, mABT1(34-102); lane 10, mABT1(34-204); lane 11, mABT1(97-204).
|
|
As was the case for TBP in HeLa nuclear extracts, purified GST-mABT1 WT
(Fig.
5C, lane 2 and 8), GST-mABT1(34-269), GST-mABT1(1-102),
and
GST-mABT1(1-204) also interacted with His-mTBP (Fig.
5C, lanes
3, 5, and 6, respectively), while GST-mABT1(1-39) (Fig.
5C, lane
4) failed to
do so. To further define the region sufficient for
complex formation,
the GST-mABT1(34-102), GST-mABT1(34-204), and
GST-mABT1(97-204) fusion
proteins were generated to examine the
complex formation. Here,
GST-mABT1(34-102) and GST-mABT1(34-204)
were observed to interact with
His-mTBP as did the WT (Fig.
5C,
lanes 9 and 10, respectively). In
contrast, GST-mABT1(97-204)
did not interact with His-mTBP at all (Fig.
5C, lane
11).
mABT1 stimulates basal transcription in vitro.
Given that
mABT1 directly interacts with TBP, we then examined whether mABT1 will
functionally participate in transcription in a reconstituted
transcription reaction. We first examined whether mABT1 stimulates
basal transcription from the AdML promoter, which contains only the
core promoter sequence without any upstream regulatory elements.
Addition of 12.5, 25, and 50 ng of GST-mABT1 to the in vitro
transcription reaction significantly stimulated transcription levels
3.6-, 4.9-, and 5.4-fold, respectively (Fig. 6, lanes 2 to 4) compared to the control
(no addition [Fig. 6, lane 1]). Addition of 12.5, 25, and 50 ng of
control GST protein also slightly enhanced transcription levels 1.2-, 1.5-, and 2.2-fold, respectively (Fig. 6, lanes 5 to 7). The
stimulatory effect of mABT1 on in vitro transcription was approximately
three times higher than that of the GST protein. The transcription
enhancement by GST-mABT1 saturated at 50 ng of GST-mABT1, and
transcription was rather inhibited at the higher dose of 200 ng of
GST-mABT1 (data not shown). These results clearly show that mABT1 can
activate basal transcription in vitro.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 6.
mABT1 stimulates transcription in a reconstituted
cell-free system. In vitro transcription from an AdML promoter was
performed with addition of increasing amounts of GST-mABT1 or GST. Lane
1, without GST-mABT1; lane 2, 12.5 ng of GST-mABT1; lane 3, 25 ng of
GST-mABT1; lane 4, 50 ng of GST-mABT1; lane 5, 12.5 ng of GST; lane 6, 25 ng of GST; lane 7, 50 ng of GST. Nuclear extract (N.E.) prepared
from rat liver was used as a positive control. Amounts of transcripts
were measured by an image analyzer (BAS 1500; Fuji), and fold
activation is indicated at the bottom.
|
|
mABT1 stimulates basal transcription in transfected cells.
It
remains to be shown whether mABT1 can activate basal transcription in
the cell. To examine this, the reporter plasmid pTATA-Luc, which
consists of a TATA box and a luciferase gene but without any
cis-regulatory elements, was cotransfected in COS7 cells
with pcDNA3-myc-mABT1, an expression vector of Myc-tagged mABT1. As the
expression of mABT1 increased, the luciferase activity from pTATA-Luc was observed to increase up to fourfold in a dose-dependent manner (Fig. 7A). We note here that
enhancement of transcription required relatively high expression levels
of mABT1. These results convincingly show that overexpression of mABT1
stimulates basal transcription in transfected cells as well as in
vitro.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 7.
mABT1 stimulates transcription in transfected cells. (A)
Coexpression of mABT1 stimulates luciferase activity from the reporter
plasmid pTATA-Luc. pTATA-Luc (0.1 µg) was cotransfected in COS7 cells
with different amounts of pcDNA3-myc-mABT1 (0 to 2 µg). The total
amount of plasmids used for each transfection was normalized with
pcDNA3-myc. The cells were cultured in DMEM-10% FBS. Following
48 h of incubation, cell lysates were prepared and subjected to
immunoblotting and luciferase assays. The expression level of Myc-mABT1
in each sample was detected by immunoblotting with an anti-Myc antibody
(inset). (B) Stimulation of luciferase activity from reporter genes
with different cis-regulatory elements by mABT1. Structures
of the reporter and expression plasmids are shown at the top. One
microgram of reporter genes containing CRE, SRE, AP-1, and NF- B
cis-regulatory elements was cotransfected with 1 µg of
pcDNA3-myc (Mock) or pcDNA3-myc-mABT1 (Myc-mABT1). The cells were
cultured in DMEM-1% BSA; after 48 h of incubation cell lysates
were prepared and subjected to luciferase assay. CMV,
cytomegalovirus.
|
|
We further tested, again by cotransfection, whether mABT1 enhances
expression from other reporter genes containing CRE, AP-1,
serum
response element SRE, and NF-

B regulatory elements. Expression
of
mABT1 repeatedly increased luciferase activity from these reporter
genes, pCRE-Luc (4-fold), pSRE-Luc (7-fold), pAP-1-Luc (5-fold),
and
pNF-

B-Luc (2.9-fold) (Fig.
7B). The enhancement of transcription
from these heterologous promoters was more or less at the same
level as
that observed for the core promoter (pTATA-Luc; fourfold
[Fig.
7A]).
This suggests that mABT1 may not act in an enhancer-specific
manner but
rather acts ubiquitously. This observation is consistent
with the idea
that mABT1 stimulates basal transcription but does
not activate
specific enhancer elements. Although Myc-tagged mABT1
was used to
monitor expression in these assays, the Myc tag did
not contribute to
enhance luciferase activity, since tagless mABT1
gave similar results
(data not
shown).
mABT1 enhances gene expression as monitored by mRNA and protein
levels.
In addition to the measurement of luciferase activity, we
confirmed the enhancement of gene expression by monitoring mRNA and
protein levels. An expression plasmid for a GAL4-CREB fusion protein
was cotransfected into COS7 cells with or without pcDNA3 Myc-mABT1.
Total RNA was collected after an incubation period, and RT-PCR analysis
was performed to quantify the amount of GAL4-CREB mRNA. As shown in
Fig. 8A, the GAL4-CREB transcript was not
detected by the RT-PCR in total RNA prepared from the COS7 cells
transfected with a GAL4-CREB expression vector and pcDNA3-myc even
after 35 cycles under these experimental conditions. In contrast, a
GAL4-CREB transcript was readily detected in total RNA prepared from
the COS7 cells transfected with the GAL-CREB expression vector and pcDNA3-myc-mABT1 after 25 cycles. We determined the amount of GAL4-CREB
protein by Western blotting using an anti-CREB antibody and found that
the amount, as well as that of GAL4-CREB mRNA, increased upon
cotransfection of mABT1 (Fig. 8B). We further studied whether mABT1
enhances gene expression in other cotransfected plasmids expressing
GAL4-Fos or GAL4-ATF2. Western blotting using an anti-GAL4 antibody
clearly showed the expression levels of the GAL4-Fos and GAL4-ATF2
chimeric proteins to drastically increase when mABT1 was coexpressed
(Fig. 8C).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 8.
mABT1 enhances mRNA and protein levels from
cotransfected genes. (A) COS7 cells were transfected with pFA-CREB with
either pcDNA3-myc (as Mock) or pcDNA3-myc-mABT1 (mABT1), and total RNA
(1 µg) was subjected to RT-PCR (RT+) or PCR without the RT reaction
(RT ). The PCRs were sampled at 15, 20, 25, 30, and 35 cycles, then
separated on 1% agarose gel, and stained with ethidium bromide. A PCR
product of 485 bp derived from the GAL4-CREB mRNA is indicated with an
arrow. (B) Immunoblotting with anti-CREB antibody. Cell lysates
prepared from the transfected COS7 cells as mentioned above were
subjected to SDS-PAGE, followed by immunoblotting with an anti-CREB
antibody. Arrows indicate the GAL4-CREB fusion protein. Two samples of
control ( ) and mABT1 (+) were independently prepared. (C)
Immunoblotting with an anti-GAL4 antibody. COS7 cells were
cotransfected with pFA-cFos or pFA-ATF2 with or without
pcDNA3-myc-mABT1. Cell lysates were prepared after 48 h and
analyzed with an anti-GAL4 antibody. Arrows indicate GAL4-Fos and
GAL4-ATF2 fusion proteins detected with the antibody. Lane 1, pFA-cFos
plus pcDNA3-myc; lane 2, pFA-cFos plus pcDNA3-myc-mABT1; lane 3, pFA-ATF2 plus pcDNA3-myc; lane 4, pFA-ATF2 plus pcDNA3-myc-mABT1).
|
|
mABT1 interacts with DNA.
To examine whether mABT1 interacts
with DNA, GST-mABT1 or control GST protein was incubated with
DNA-cellulose. GST-mABT1, but not GST, was captured by both native
DNA-cellulose (Fig. 9, lane 4) and
denatured DNA-cellulose (Fig. 9, lane 6). The amount of GST-mABT1
protein bound to the cellulose was approximately one-third to one-fifth
of the input (Fig. 9, compare lane 2 with lane 4 or 6). These results
suggest that mABT1 directly binds to single- and double-stranded DNA.
To examine stability of the binding, we washed the complex with 0.1 to
1.0 M NaCl. GST-mABT1 bound to both DNA-celluloses dissociated at 1.0 M
NaCl but did not dissociate at 0.8 M NaCl (data not shown). In this
assay, some degradation of GST-mABT1 was detected. We do not know
whether these degradation products retain DNA-binding ability, since
they might be captured by the dimerization of GST (65)
between the degradation products and the intact GST-mABT1.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 9.
mABT1 interacts with DNA. GST or GST-mABT1 (Input; lanes
1 and 2) were incubated with native DNA-cellulose (lanes 3 and 4) or
denatured DNA-cellulose (lanes 5 and 6). After washing with PBS
containing 0.1% Triton X-100, proteins bound to cellulose were
subjected to SDS-PAGE and stained with Coomassie brilliant blue.
GST-mABT1, but not GST, was captured by both native and denatured
DNA-cellulose (lanes 4 and 6). Degradations of GST-mABT1 are indicated
by an asterisk.
|
|
 |
DISCUSSION |
Recent studies aimed at understanding the molecular mechanism of
transcriptional regulation have unraveled a battery of proteins participating in various aspects of the transcriptional event (4,
30, 39, 53, 56, 67). TBP in particular has been recognized as one
of the central factors that help multiple proteins to assemble into a
large complex leading to transcriptional initiation and regulation
(39). To further advance our knowledge, it is important to
identify all of the TBP-binding proteins and relevant factors. In the
present study, we have described the investigation and resulting
characterization of a novel TBP-binding protein, mABT1.
mABT1 is a TBP-binding protein.
ABT1 was found to be
ubiquitously expressed in a variety of mouse tissues and conserved from
yeast to mammalian cells, suggesting an elementary role of ABT1 in
cells. Indeed, the importance of ABT1 was explicitly shown in yeast
cells, as the ABT1-deficient cells were unable to grow. We first tested
whether mABT1 is involved in transcription, since mABT1 is a nuclear
protein and has a characteristic acidic region, which has been
described as a transcriptional activation domain in many transcription
factors (e.g., VP16, GAL4, GCN4, and p53) (12, 15, 24, 49, 54,
64). Since several transcription factors have been shown to
interact with TBP or TFIID, we examined whether mABT1 also interacts
with TBP. In fact, mABT1 was found to interact with TBP directly,
indicating that mABT1 can be added to the growing list of TBP-binding
proteins. Interestingly, mABT1 and TBP could not associate under the
high ionic strength of 0.4 M NaCl or 0.5 M guanidine hydrochloride in
vitro. Thus, this association appears to be unstable compared with the
association between TBP and TAFIIs, which is resistant to
0.5 M guanidine hydrochloride (21, 51). This may be one of
the reasons why ABT1 has not previously been identified as a
TAFII by conventional immunopurification methods using
anti-TBP antibody (9). Although less stable, mABT1-TBP
binding could be demonstrated by coimmunoprecipitation in
mABT1-transfected cells, indicating that association can occur in the cell.
The fact that TBP can bind so many proteins raises the interesting
question of whether this binding occur simultaneously on
the same TBP
molecule or on different TBP molecules. A quantitative
Western blot
analysis has shown that the concentration of TBP
in the cell is
sufficient to permit independent interactions with
each of the
TBP-binding proteins, including TAF
Is, TAF
IIs,
TAF
IIIs,
SAGA, Mot1, NC2, and NOTs (
39).
According to this scheme, mABT1
may interact with a small population of
a large global pool of
TBP and form a complex with TBP which is not
bound to other
proteins.
By using a series of mABT1 mutants, we determined that the mABT1 region
encompassing residues 34 to 102 is responsible for
TBP binding. This
domain is well conserved among different species,
indicating that the
interaction may be an evolutionarily conserved
feature of this protein.
TBP-binding motifs in several TBP-binding
proteins have been reported
(
29), but we were not able to locate
these motifs in the
TBP-binding region of
mABT1.
mABT1 activates basal transcription.
Since mABT1 binds to TBP,
we examined whether mABT1 is involved in transcriptional regulation in
a reconstituted cell-free transcription system. mABT1 increased up to
threefold in vitro transcription from the AdML promoter in a
dose-dependent manner. The level of transcription was inhibited at
higher concentrations, possibly due to sequestering of the functional
TBP from the promoter DNA. Given that mABT1 binds to TBP, it is likely
that functional interaction can occur between mABT1 and the basal
transcriptional machinery. The ability of mABT1 to enhance basal
transcription appears to render the protein distinct from mammalian
TAFIIs (67), which usually do not affect basal
transcription but only mediate the response of specific activators.
TAFIIs typically act as molecular bridges between specific
activators and the general transcription machinery. For example,
TAFII110 mediates activation of Sp1 (7, 21, 70),
and TAFII40 mediates activation of GAL4-VP16 in cell-free systems (16).
In transfection experiments, we showed that coexpression of mABT1
enhanced transcription from a minimal core promoter and
to the same
extent from promoters with CRE, SRE, AP-1, and NF-

B
cis-regulatory elements. Importantly, mABT1 does not
function
as a specific regulatory factor for CRE, SRE, AP-1, and
NF-

B
cis-regulatory elements; only the core promoter is
sufficient
for this effect. This result is compatible with the notion
that
mABT1 can activate basal transcription. Again, this feature
appears
to differentiate mABT1 from TAF
IIs, in that
TAF
II40, TAF
II60,
TAF
II110, and
TAF
II230 have been shown not to affect basal transcription
in cotransfection experiments (
11). Taken together, these
results
show that mABT1 is unique in possessing TBP-binding and basal
transcription activities, a feature distinguishing it from typical
TAF
IIs, which act in a regulator-specific
manner.
Recently, a distinct class of factors that activate basal transcription
has been identified in yeast. For example, the yeast
Tsp1/Sub1 protein,
which has sequence similarity to the human
coactivator PC4, stimulates
basal transcription in vitro (
19,
35). Also, the yeast
mediator, which consists of approximately
20 polypeptides, interacts
with the C-terminal repeat domain of
Pol II and stimulates basal
transcription in vitro (
34,
36).
Whether ScABT1 is included
in the mediator complex and activates
basal transcription remains to be
clarified. Tsp1/Sub1 and the
mediator have been reported to stimulate
activated transcription
as well as basal transcription. It will be
interesting to determine
whether mABT1 stimulates activated
transcription. Interestingly,
mABT1 can bind to DNA in a
sequence-independent manner. This feature
of mABT1 suggests that it
could be a transcription cofactor, since
well-characterized
human-positive cofactors such as topoisomerase
I (
37,
43,
61), topoisomerase II (
5), poly(ADP-ribose)
polymerase, HMG2 (
14,
28,
60,
62,
71,
72), and PC4
(
31) are DNA-binding proteins which may affect accessibility
to DNA and modulate the activity of RNA Pol II (
30). The
precise
mechanism of how mABT1 exerts its effect on basal transcription
remains to be elucidated. Since mABT1 binds to TBP and DNA, we
favor
the view that mABT1 accelerates or facilitates assembly
of the
transcriptional initiation complex. However, we cannot
totally exclude
the possibility that mABT1 affects mRNA stability
or transcription
elongation. Recently, TBP has been shown to form
homodimers and needs
to dissociate to acquire TATA element binding
and activate
transcription. Thus, it is thought that TBP dimerization
prevents
unregulated gene expression (
27,
63). Along the same
line,
mABT1 might accelerate the dissociation of TBP dimers by
binding to TBP
and as a result increase the accessibility of TBP
to promoter DNA,
thereby enhancing basal transcription. To further
dissect the molecular
mechanism of mABT1 function, it is important
to explain which proteins
mABT1 interacts with, that is, whether
mABT1 binds to GTFs, Pol II,
TAF
IIs, or other factors included
in the preinitiation
complex. Yeast two-hybrid screening using
mABT1 is under way in our
laboratory. mABT1-associated proteins
may represent a novel
protein-protein complex involved in the
regulation of basal
transcription. Although mABT1 has an acidic
region in its N terminus,
the function of this region in transcriptional
activation has not been
elucidated.
We have provided evidence that mABT1 can act as a regulator of basal
transcription for class II genes. However, we still do
not know whether
mABT1 can act on class I and class III promoters.
Since TBP is included
in the transcriptional machinery of class
I and class III promoters
(
39), and since mABT1 resides in the
nucleolus, these
possibilities may be worth testing in the future.
Also, it would be
interesting to examine if SHD or other SH2 domain-containing
proteins
regulate mABT1
function.
 |
ACKNOWLEDGMENTS |
We thank Y. Makino for the donation of TBP cDNA and for
suggestions, and we thank H. Tokumitsu for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Helix Research
Institute, Inc., 1532-3 Yana, Kisarazu-shi, Chiba 292-0812, Japan.
Phone: 81 (0)438-52-3966. Fax: 81 (0)438-52-3952. E-mail:
mmasaaki{at}hri.co.jp.
 |
REFERENCES |
| 1.
|
Auble, D. T., and S. Hahn.
1993.
An ATP-dependent inhibitor of TBP binding to DNA.
Genes Dev.
7:844-856[Abstract/Free Full Text].
|
| 2.
|
Auble, D. T.,
K. E. Hansen,
C. G. Mueller,
W. S. Lane,
J. Thorner, and S. Hahn.
1994.
Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism.
Genes Dev.
8:1920-1934[Abstract/Free Full Text].
|
| 3.
|
Barlev, N. A.,
R. Candau,
L. Wang,
P. Darpino,
N. Silverman, and S. L. Berger.
1995.
Characterization of physical interactions of the putative transcriptional adaptor, ADA2, with acidic activation domains and TATA-binding protein.
J. Biol. Chem.
270:19337-19344[Abstract/Free Full Text].
|
| 4.
|
Björklund, S., and Y.-J. Kim.
1996.
Mediator of transcriptional regulation.
Trends Biochem. Sci.
21:335-337[CrossRef][Medline].
|
| 5.
|
Brou, C.,
A. Kuhn,
A. Staub,
S. Chaudhary,
I. Grummt,
I. Davidson, and L. Tora.
1993.
Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II.
Nucleic Acids Res.
21:4011-4018[Abstract/Free Full Text].
|
| 6.
|
Chang, M., and J. A. Jaehning.
1997.
A multiplicity of mediators: alternative forms of transcription complexes communicate with transcriptional regulators.
Nucleic Acids Res.
25:4861-4865[Abstract/Free Full Text].
|
| 7.
|
Chen, J. L.,
L. D. Attardi,
C. P. Verrijzer,
K. Yokomori, and R. Tjian.
1994.
Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators.
Cell
79:93-105[CrossRef][Medline].
|
| 8.
|
Dikstein, R.,
S. Ruppert, and R. Tjian.
1996.
TAFII250 is a bipartite protein kinase that phosphorylates the basal transcription factor RAP74.
Cell
84:781-790[CrossRef][Medline].
|
| 9.
|
Dynlacht, B. D.,
T. Hoey, and R. Tjian.
1991.
Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation.
Cell
66:563-576[CrossRef][Medline].
|
| 10.
|
Eisenmann, D. M.,
K. M. Arndt,
S. L. Ricupero,
J. W. Rooney, and F. Winston.
1992.
SPT3 interacts with TFIID to allow normal transcription in Saccharomyces cerevisiae.
Genes Dev.
6:1319-1331[Abstract/Free Full Text].
|
| 11.
|
Farmer, G.,
J. Colgan,
Y. Nakatani,
J. L. Manley, and C. Prives.
1996.
Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo.
Mol. Cell. Biol.
16:4295-4304[Abstract].
|
| 12.
|
Friedman, A. D.,
S. J. Triezenberg, and S. L. McKnight.
1988.
Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus.
Nature
335:452-454[CrossRef][Medline].
|
| 13.
|
Gasch, A.,
A. Hoffmann,
M. Horikoshi,
R. G. Roeder, and N. H. Chua.
1990.
Arabidopsis thaliana contains two genes for TFIID.
Nature
346:390-394[CrossRef][Medline].
|
| 14.
|
Ge, H., and R. G. Roeder.
1994.
The high mobility group protein HMG1 can reversibly inhibit class II gene transcription by interaction with the TATA-binding protein.
J. Biol. Chem.
269:17136-17140[Abstract/Free Full Text].
|
| 15.
|
Gill, G., and M. Ptashne.
1987.
Mutants of GAL4 protein altered in an activation function.
Cell
51:121-126[CrossRef][Medline].
|
| 16.
|
Goodrich, J. A.,
T. Hoey,
C. J. Thut,
A. Admon, and R. Tjian.
1993.
Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB.
Cell
75:519-530[CrossRef][Medline].
|
| 17.
|
Goppelt, A.,
G. Stelzer,
F. Lottspeich, and M. Meisterernst.
1996.
A mechanism for repression of class II gene transcription through specific binding of NC2 to TBP-promoter complexes via heterodimeric histone fold domains.
EMBO J.
15:3105-3116[Medline].
|
| 18.
|
Hateboer, G.,
H. T. Timmers,
A. K. Rustgi,
M. Billaud,
L. J. van't Veer, and R. Bernards.
1993.
TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein.
Proc. Natl. Acad. Sci. USA
90:8489-8493[Abstract/Free Full Text].
|
| 19.
|
Henry, N. L.,
D. A. Bushnell, and R. D. Kornberg.
1996.
A yeast transcriptional stimulatory protein similar to human PC4.
J. Biol. Chem.
271:21842-21847[Abstract/Free Full Text].
|
| 20.
|
Hoey, T.,
B. D. Dynlacht,
M. G. Peterson,
B. F. Pugh, and R. Tjian.
1990.
Isolation and characterization of the Drosophila gene encoding the TATA box binding protein, TFIID.
Cell
61:1179-1186[CrossRef][Medline].
|
| 21.
|
Hoey, T.,
R. O. Weinzierl,
G. Gill,
J. L. Chen,
B. D. Dynlacht, and R. Tjian.
1993.
Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators.
Cell
72:247-260[CrossRef][Medline].
|
| 22.
|
Hoffmann, A.,
M. Horikoshi,
C. K. Wang,
S. Schroeder,
P. A. Weil, and R. G. Roeder.
1990.
Cloning of the Schizosaccharomyces pombe TFIID gene reveals a strong conservation of functional domains present in Saccharomyces cerevisiae TFIID.
Genes Dev.
4:1141-1148[Abstract/Free Full Text].
|
| 23.
|
Hoffmann, A.,
E. Sinn,
T. Yamamoto,
J. Wang,
A. Roy,
M. Horikoshi, and R. G. Roeder.
1990.
Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID).
Nature
346:387-390[CrossRef][Medline].
|
| 24.
|
Hope, I. A., and K. Struhl.
1986.
Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.
Cell
46:885-894[CrossRef][Medline].
|
| 25.
|
Horikoshi, M.,
C. K. Wang,
H. Fujii,
J. A. Cromlish,
P. A. Weil, and R. G. Roeder.
1989.
Cloning and structure of a yeast gene encoding a general transcription initiation factor TFIID that binds to the TATA box.
Nature
341:299-303[CrossRef][Medline].
|
| 26.
|
Inostroza, J. A.,
F. H. Mermelstein,
I. Ha,
W. S. Lane, and D. Reinberg.
1992.
Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription.
Cell
70:477-489[CrossRef][Medline].
|
| 27.
|
Jackson-Fisher, A. J.,
C. Chitikila,
M. Mitra, and B. F. Pugh.
1999.
A role for TBP dimerization in preventing unregulated gene expression.
Mol. Cell
3:717-727[CrossRef][Medline].
|
| 28.
|
Jayaraman, L.,
N. C. Moorthy,
K. G. K. Murthy,
J. L. Manley, and C. Prives.
1998.
High mobility group protein-1 (HMG-1) is a unique activator of p53.
Genes Dev.
12:462-472[Abstract/Free Full Text].
|
| 29.
|
Jiang, S.-W., and N. L. Eberhardt.
1996.
TEF-1 transrepression in Be Wo cells is mediated through interactions with the TATA-binding protein, TBP.
J. Biol. Chem.
271:9510-9518[Abstract/Free Full Text].
|
| 30.
|
Kaiser, K., and M. Meisterernst.
1996.
The human general co-factors.
Trends Biochem. Sci.
21:342-345[CrossRef][Medline].
|
| 31.
|
Kaiser, K.,
G. Stelzer, and M. Meisterernst.
1995.
The coactivator p15 (PC4) initiates transcriptional activation during TFIIA-TFIID-promoter complex formation.
EMBO J.
14:3520-3527[Medline].
|
| 32.
|
Kao, C. C.,
P. M. Lieberman,
M. C. Schmidt,
Q. Zhou,
R. Pei, and A. J. Berk.
1990.
Cloning of a transcriptionally active human TATA binding factor.
Science
248:1646-1650[Abstract/Free Full Text].
|
| 33.
|
Kim, T. K.,
Y. Zhao,
H. Ge,
R. Bernstein, and R. G. Roeder.
1995.
TATA-binding protein residues implicated in a functional interplay between negative cofactor NC2 (Dr1) and general factors TFIIA and TFIIB.
J. Biol. Chem.
270:10976-10981[Abstract/Free Full Text].
|
| 34.
|
Kim, Y.-J.,
S. Björklund,
Y. Li,
M. H. Sayre, and R. D. Kornberg.
1994.
A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II.
Cell
77:599-608[CrossRef][Medline].
|
| 35.
|
Knaus, R.,
R. Pollock, and L. Guarente.
1996.
Yeast SUB1 is a suppressor of TFIIB mutations and has homology to the human co-activator PC4.
EMBO J.
15:1933-1940[Medline].
|
| 36.
|
Koleske, A. J., and R. A. Young.
1994.
An RNA polymerase II holoenzyme responsive to activators.
Nature
368:466-469[CrossRef][Medline].
|
| 37.
|
Kretzschmar, M.,
M. Meisterernst, and R. G. Roeder.
1993.
Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II.
Proc. Natl. Acad. Sci. USA
90:11508-11512[Abstract/Free Full Text].
|
| 38.
|
Lee, T. I.,
J. J. Wyrick,
S. S. Koh,
E. G. Jennings,
E. L. Gadbois, and R. A. Young.
1998.
Interplay of positive and negative regulators in transcription initiation by RNA polymerase II holoenzyme.
Mol. Cell. Biol.
18:4455-4462[Abstract/Free Full Text].
|
| 39.
|
Lee, T. I., and R. A. Young.
1998.
Regulation of gene expression by TBP-associated proteins.
Genes Dev.
12:1398-1408[Free Full Text].
|
| 40.
|
Maheswaran, S.,
H. Lee, and G. E. Sonenshein.
1994.
Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein.
Mol. Cell. Biol.
14:1147-1152[Abstract/Free Full Text].
|
| 41.
|
Martinez, E.,
H. Ge,
Y. Tao,
C.-X. Yuan,
V. Palhan, and R. G. Roeder.
1998.
Novel cofactors and TFIIA mediate functional core promoter selectivity by the human TAFII150-containing TFIID complex.
Mol. Cell. Biol.
18:6571-6583[Abstract/Free Full Text].
|
| 42.
|
Meisterernst, M., and R. G. Roeder.
1991.
Family of proteins that interact with TFIID and regulate promoter activity.
Cell
67:557-567[CrossRef][Medline].
|
| 43.
|
Merino, A.,
K. R. Madden,
W. S. Lane,
J. J. Champoux, and D. Reinberg.
1993.
DNA topoisomerase I is involved in both repression and activation of transcription.
Nature
365:227-232[CrossRef][Medline].
|
| 44.
|
Mermelstein, F.,
K. Yeung,
J. Cao,
J. A. Inostroza,
H. Erdjument-Bromage,
K. Eagelson,
D. Landsman,
P. Levitt,
P. Tempst, and D. Reinberg.
1996.
Requirement of a corepressor for Dr-1 mediated repression of transcription.
Genes Dev.
10:1033-1048[Abstract/Free Full Text].
|
| 45.
|
Metz, R.,
A. J. Bannister,
J. A. Sutherland,
C. Hagemeier,
E. C. O'Rourke,
A. Cook,
R. Bravo, and T. Kouzarides.
1994.
c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein.
Mol. Cell. Biol.
14:6021-6029[Abstract/Free Full Text].
|
| 46.
|
Mizzen, C. A.,
X.-J. Yang,
T. Kokubo,
J. E. Brownell,
A. J. Bannister,
T. Owen-Hughes,
J. Workman,
L. Wang,
S. L. Berger,
T. Kouzarides,
Y. Nakatani, and C. D. Allis.
1996.
The TAFII250 subunit of TFIID has histone acetyltransferase activity.
Cell
87:1261-1270[CrossRef][Medline].
|
| 47.
|
Moqtaderi, Z.,
Y. Bai,
D. Poon,
P. A. Weil, and K. Struhl.
1996.
TBP-associated factors are not generally required for transcriptional activation in yeast.
Nature
383:188-191[CrossRef][Medline].
|
| 48.
|
Oda, T.,
J. Kujovich,
M. Reis,
B. Newman, and B. J. Druker.
1997.
Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
Oncogene
15:1255-1262[CrossRef][Medline].
|
| 49.
|
Oliner, J. D.,
J. A. Pietenpol,
S. Thiagalingam,
J. Gyuris,
K. W. Kinzler, and B. Vogelstein.
1993.
Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53.
Nature
362:857-860[CrossRef][Medline].
|
| 50.
|
Pugh, B. F., and R. Tjian.
1990.
Mechanism of transcriptional activation by Sp1: evidence for coactivators.
Cell
61:1187-1197[CrossRef][Medline].
|
| 51.
|
Pugh, B. F., and R. Tjian.
1991.
Transcription from a TATA-less promoter requires a multisubunit TFIID complex.
Genes Dev.
5:1935-1945[Abstract/Free Full Text].
|
| 52.
|
Ransone, L. J.,
L. D. Kerr,
M. J. Schmitt,
P. Wamsley, and I. M. Verma.
1993.
The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.
Gene Expr.
3:37-48[Medline].
|
| 53.
|
Roeder, R. G.
1996.
The role of general initiation factors in transcription by RNA polymerase II.
Trends Biochem. Sci.
21:327-335[CrossRef][Medline].
|
| 54.
|
Sadowski, I.,
J. Ma,
S. Triezenberg, and M. Ptashne.
1988.
GAL4-VP16 is an unusually potent transcriptional activator.
Nature
335:563-564[CrossRef][Medline].
|
| 55.
|
Saleh, A.,
V. Lang,
R. Cook, and C. J. Brandl.
1997.
Identification of native complexes containing the yeast coactivator/repressor proteins NGG1/ADA3 and ADA2.
J. Biol. Chem.
272:5571-5578[Abstract/Free Full Text].
|
| 56.
|
Sauer, F., and R. Tjian.
1997.
Mechanisms of transcriptional activation: differences and similarities between yeast, Drosophila, and man.
Curr. Opin. Genet. Dev.
7:176-181[CrossRef][Medline].
|
| 57.
|
Sawadogo, M., and R. G. Roeder.
1985.
Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay.
Proc. Natl. Acad. Sci. USA
82:4394-4398[Abstract/Free Full Text].
|
| 58.
|
Seto, E.,
A. Usheva,
G. P. Zambetti,
J. Momand,
N. Horikoshi,
R. Weinmann,
A. J. Levine, and T. Shenk.
1992.
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Proc. Natl. Acad. Sci. USA
89:12028-12032[Abstract/Free Full Text].
|
| 59.
|
Shen, W.-C., and M. R. Green.
1997.
Yeast TAFII145 functions as a core promoter selectivity factor, not a general coactivator.
Cell
90:615-624[CrossRef][Medline].
|
| 60.
|
Shykind, B. M.,
J. Kim, and P. A. Sharp.
1995.
Activation of the TFIID-TFIIA complex with HMG-2.
Genes Dev.
9:1354-1365[Abstract/Free Full Text].
|
| 61.
|
Shykind, B. M.,
J. Kim,
L. Stewart,
J. J. Champoux, and P. A. Sharp.
1997.
Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription.
Genes Dev.
11:397-407[Abstract/Free Full Text].
|
| 62.
|
Stelzer, G.,
A. Goppelt,
F. Lottspeich, and M. Meisterernst.
1994.
Repression of basal transcription by HMG2 is counteracted by TFIIH-associated factors in an ATP-dependent process.
Mol. Cell. Biol.
7:4712-4721.
|
| 63.
|
Taggart, A. K. P., and B. F. Pugh.
1996.
Dimerization of TFIID when not bound to DNA.
Science
272:1331-1333[Abstract].
|
| 64.
|
Truant, R.,
H. Xiao,
C. J. Ingles, and J. Greenblatt.
1993.
Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein.
J. Biol. Chem.
268:2284-2287[Abstract/Free Full Text].
|
| 65.
|
Tudyka, T., and A. Skerra.
1997.
Glutathione S-transferase can be used as a C-terminal, enzymatically active dimerization module for a recombinant protease inhibitor, and functionally secreted into the periplasm of Escherichia coli.
Protein Sci.
6:2180-2187[Medline].
|
| 66.
|
Uemura, H., and Y. Jigami.
1995.
Mutations in GCR1, a transcriptional activator of Saccharomyces cerevisiae glycolytic genes, function as suppressors of gcr2 mutations.
Genetics
139:511-521[Abstract].
|
| 67.
|
Verrijzer, C. P., and R. Tjian.
1996.
TAFs mediate transcriptional activation and promoter selectivity.
Trends Biochem. Sci.
21:338-342[CrossRef][Medline].
|
| 68.
|
Wach, A.,
A. Brachat,
R. Pohlmann, and P. Philippsen.
1994.
New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae.
Yeast
10:1793-1808[CrossRef][Medline].
|
| 69.
|
Wade, P. A., and J. A. Jaehning.
1996.
Transcriptional corepression in vitro: a Mot1p-associated form of TATA-binding protein is required for repression by Leu3p.
Mol. Cell. Biol.
16:1641-1648[Abstract].
|
| 70.
|
Weinzierl, R. O.,
B. D. Dynlacht, and R. Tjian.
1993.
Largest subunit of Drosophila transcription factor IID directs assembly of a complex containing TBP and a coactivator.
Nature
362:511-577[CrossRef][Medline].
|
| 71.
|
Zappavigna, V.,
M. Falciola,
M. Citterich,
F. Mavilio, and M. E. Bianchi.
1996.
HMG1 interacts with HOX proteins and enhances DNA binding and transcriptional activation.
EMBO J.
15:4981-4991[Medline].
|
| 72.
|
Zwilling, S.,
H. Koenig, and T. Wirth.
1995.
High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.
EMBO J.
14:1198-1208[Medline].
|
Molecular and Cellular Biology, February 2000, p. 1407-1418, Vol. 20, No. 4
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
de Planell-Saguer, M., Schroeder, D. G., Rodicio, M. C., Cox, G. A., Mourelatos, Z.
(2009). Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery. Hum Mol Genet
18: 2115-2126
[Abstract]
[Full Text]
-
Oda, T., Hayano, T., Miyaso, H., Takahashi, N., Yamashita, T.
(2007). Hsp90 regulates the Fanconi anemia DNA damage response pathway. Blood
109: 5016-5026
[Abstract]
[Full Text]
-
Hoang, T., Peng, W.-T., Vanrobays, E., Krogan, N., Hiley, S., Beyer, A. L., Osheim, Y. N., Greenblatt, J., Hughes, T. R., Lafontaine, D. L. J.
(2005). Esf2p, a U3-Associated Factor Required for Small-Subunit Processome Assembly and Compaction. Mol. Cell. Biol.
25: 5523-5534
[Abstract]
[Full Text]
-
Yagasaki, H., Adachi, D., Oda, T., Garcia-Higuera, I., Tetteh, N., D'Andrea, A. D., Futaki, M., Asano, S., Yamashita, T.
(2001). A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA. Blood
98: 3650-3657
[Abstract]
[Full Text]